Heart failure and diabetes: Understanding the bidirectional relationship

被引:13
作者
Elendu, Chukwuka [1 ]
Amaechi, Dependable C. [2 ]
Elendu, Tochi C. [3 ]
Ashna, Manizha [4 ]
Ross-Comptis, Jennifer [5 ]
Ansong, Sandra O. [6 ]
Egbunu, Emmanuel O. [7 ]
Okafor, Geraldine C. [8 ]
Jingwa, Klein A. [9 ]
Akintunde, Akinbayo A. [10 ]
Ogah, Chidinma M. [10 ]
Edeko, Melissa O. [10 ]
Ibitoye, Ayodeji V. [10 ]
Ogunseye, Mojetoluwa O. [11 ]
Alakwe-Ojimba, Chisom E. [12 ]
Omeludike, Eunice K. [13 ]
Oguine, Chibuike A. [10 ]
Afuh, Rechner N. [14 ]
Olawuni, Clinton A. [15 ]
Ekwem, Onyekachukwu R. [16 ]
Oyedele, Boluwatife A. [10 ]
Pius, Erica I. [10 ]
Asekhauno, Mercy O. [10 ]
Ladele, John A. [10 ]
Okoro, Chinonso B. [17 ]
Monika Pouekoua, Brandon C. [18 ]
Adenikinju, Joseph S. [19 ]
Agu-ben, Chigozirim M. [20 ]
Aborisade, Ooreofe [21 ]
机构
[1] Fed Univ Teaching Hosp Owerri, Owerri 460281, Nigeria
[2] Igbinedion Univ, Okada, Nigeria
[3] Imo State Univ, Owerri, Nigeria
[4] Univ Ottawa, Ottawa, ON, Canada
[5] Larkin Community Hosp, Doral, FL USA
[6] Catholic Hosp Battor, Bator, Ghana
[7] Fed Med Ctr Bida, Bida, Nigeria
[8] Univ Nigeria Teaching Hosp, Enugu, Nigeria
[9] Kazan State Med Univ, Kazan, Russia
[10] Babcock Univ, Ilisan, Nigeria
[11] Natl Pirogov Mem Med Univ, Vinnytsia, Ukraine
[12] Chukwuemeka Odumegwu Ojukwu Univ, Uli, Atughobi, Nigeria
[13] Univ Port Harcourt, Port Harcourt, Nigeria
[14] Manor Hosp, Oxford, England
[15] Gen Hosp, Lagos, Nigeria
[16] Delta State Univ, Uruoka, Delta, Nigeria
[17] Fed Med Ctr Owerri, Owerri, Nigeria
[18] Univ Bamenda, Bamenda, Cameroon
[19] Northwick Pk Hosp London Northwest NHS Trust, Abuja, Nigeria
[20] Kharkiv Nationa Med Univ, Kharkiv, Ukraine
[21] Olabisi Onabanjo Univ Teaching Hosp, Shagamu, Nigeria
关键词
bidirectional relationship; diabetes mellitus; GLP-1 receptor agonists; heart failure; SGLT2; inhibitors; CARDIOVASCULAR OUTCOMES; RISK; COMPLICATION; ENALAPRIL; DISEASE;
D O I
10.1097/MD.0000000000034906
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heart failure and diabetes mellitus are 2 common and closely intertwined chronic conditions that often coexist in individuals. The relationship between heart failure and diabetes is bidirectional, meaning that each condition can influence the development and progression of the other. Understanding this complex interplay is crucial for optimizing the management and outcomes of patients with these comorbidities. This review comprehensively analyzed the literature to examine the bidirectional relationship between heart failure and diabetes. We searched various electronic databases and included studies that explored the pathophysiological mechanisms, epidemiology, clinical implications, and therapeutic considerations associated with this relationship. The bidirectional relationship between heart failure and diabetes is multifactorial and involves several interconnected mechanisms. Diabetes is a recognized risk factor for heart failure, increasing the risk of its development and accelerating its progression. On the other hand, heart failure can contribute to the development of insulin resistance and worsen glycemic control in patients with diabetes. Shared risk factors, such as obesity, hypertension, and dyslipidemia, contribute to development of both conditions. Additionally, hyperglycemia, insulin resistance, chronic inflammation, oxidative stress, and mitochondrial dysfunction play significant roles in the pathogenesis of heart failure in individuals with diabetes. The bidirectional relationship between heart failure and diabetes has important clinical implications. Patients with heart failure and diabetes have worse outcomes, including higher hospitalization rates, morbidity, and mortality, than those without diabetes. Optimal management strategies should target both conditions simultaneously, focusing on lifestyle modifications, pharmacotherapy, glycemic control, and cardiovascular risk reduction.
引用
收藏
页数:7
相关论文
共 40 条
  • [31] Heart Failure: The Most Important, Preventable, and Treatable Cardiovascular Complication of Type 2 Diabetes
    Packer, Milton
    [J]. DIABETES CARE, 2018, 41 (01) : 11 - 13
  • [32] Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies
    Pocock, Stuart J.
    Ariti, Cono A.
    McMurray, John J. V.
    Maggioni, Aldo
    Kober, Lars
    Squire, Iain B.
    Swedberg, Karl
    Dobson, Joanna
    Poppe, Katrina K.
    Whalley, Gillian A.
    Doughty, Rob N.
    [J]. EUROPEAN HEART JOURNAL, 2013, 34 (19) : 1404 - 1413
  • [33] 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
    Ponikowski, Piotr
    Voors, Adriaan A.
    Anker, Stefan D.
    Bueno, Hector
    Cleland, John G. F.
    Coats, Andrew J. S.
    Falk, Volkmar
    Ramon Gonzalez-Juanatey, Jose
    Harjola, Veli-Pekka
    Jankowska, Ewa A.
    Jessup, Mariell
    Linde, Cecilia
    Nihoyannopoulos, Petros
    Parissis, John T.
    Pieske, Burkert
    Riley, Jillian P.
    Rosano, Giuseppe M. C.
    Ruilope, Luis M.
    Ruschitzka, Frank
    Rutten, Frans H.
    van der Meer, Peter
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 (27) : 2129 - U130
  • [34] Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes
    Rawshani, Aidin
    Rawshani, Araz
    Franzen, Stefan
    Sattar, Naveed
    Eliasson, Bjorn
    Svensson, Ann-Marie
    Zethelius, Bjorn
    Miftaraj, Mervete
    McGuire, Darren K.
    Rosengren, Annika
    Gudbjornsdottir, Soffia
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (07) : 633 - 644
  • [35] VALIDITY OF THE MINNESOTA LIVING WITH HEART-FAILURE QUESTIONNAIRE AS A MEASURE OF THERAPEUTIC RESPONSE TO ENALAPRIL OR PLACEBO
    RECTOR, TS
    KUBO, SH
    COHN, JN
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1993, 71 (12) : 1106 - 1107
  • [36] Savarese Gianluigi, 2017, Card Fail Rev, V3, P7, DOI 10.15420/cfr.2016:25:2
  • [37] Diabetes, cardiovascular disease and the microcirculation
    Strain, W. David
    Paldanius, P. M.
    [J]. CARDIOVASCULAR DIABETOLOGY, 2018, 17
  • [38] Yancy CW, 2017, CIRCULATION, V136, pE137, DOI [10.1161/CIR.0000000000000509, 10.1016/j.cardfail.2017.04.014]
  • [39] SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
    Zelniker, Thomas A.
    Wiviott, Stephen D.
    Raz, Itamar
    Im, Kyungah
    Goodrich, Erica L.
    Bonaca, Marc P.
    Mosenzon, Ofri
    Kato, Eri T.
    Cahn, Avivit
    Furtado, Remo H. M.
    Bhatt, Deepak L.
    Leiter, Lawrence A.
    McGuire, Darren K.
    Wilding, John P. H.
    Sabatine, Marc S.
    [J]. LANCET, 2019, 393 (10166) : 31 - 39
  • [40] Epidemiology and aetiology of heart failure
    Ziaeian, Boback
    Fonarow, Gregg C.
    [J]. NATURE REVIEWS CARDIOLOGY, 2016, 13 (06) : 368 - 378